Skip to content
LULULUD12D12D12

Drawing based on the label description. No photo yet.

“Niacin extended-release tablets USP are supplied as orange coloured, film-coated, capsule-shaped tablets containing 750 mg of niacin in an extended-release formulation. Tablets are debossed "LU" on one side and "D12" on the other side”

LU D12 pill

Pill with imprint LU D12 is orange, capsule, 19 mm and has been identified as Niacin 750 mg. It is used for high cholesterol, high triglycerides and poor circulation. It is supplied by Lupin Pharmaceuticals, Inc.

Niacin 750 mg

Imprint
LU D12
Strength
750 mg
Used for
High cholesterol, high triglycerides and poor circulation
Color
Orange
Shape
Capsule / oblong
Size
19 mm
Score
No score line
Form
Tablet, extended release
Manufacturer
Lupin Pharmaceuticals, Inc
Drug class
Nicotinic acid
NDC
68180-222, 68180-222-01, 68180-222-02

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Niacin pills and guides

What is Niacin used for?

Niacin is used for high cholesterol, high triglycerides and poor circulation.

Medicine type
Nicotinic acid
Official uses from the US prescribing label

Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. Niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate.

  1. Niacin extended-release tablets are indicated to reduce elevated TC, LDL-C, Apo B and TG levels, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia.
  2. In patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction.
  3. In patients with a history of coronary artery disease (CAD) and hyperlipidemia, niacin, in combination with a bile acid binding resin, is indicated to slow progression or promote regression of atherosclerotic disease.
  4. Niacin extended-release tablets in combination with a bile acid binding resin is indicated to reduce elevated TC and LDL-C levels in adult patients with primary hyperlipidemia.
  5. Niacin is also indicated as adjunctive therapy for treatment of adult patients with severe hypertriglyceridemia who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them.

Limitations of Use

Addition of niacin extended-release tablets did not reduce cardiovascular morbidity or mortality among patients treated with simvastatin in a large, randomized controlled trial (AIM-HIGH).

From the FDA-approved label on DailyMed (published Sep 18, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows LU and the other side shows D12.
  • It is orange, capsule, 19 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Niacin

Inactive: Fd&c Yellow No. 6, Ferric Oxide Yellow, Hypromelloses, Silicon Dioxide, Stearic Acid, Cellulose, Microcrystalline, Povidone, Titanium Dioxide, Ferric Oxide Red, Polyethylene Glycol, Unspecified

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Niacin pills